| Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities M Sedighi, A Zahedi Bialvaei, MR Hamblin, E Ohadi, A Asadi, ... Cancer medicine 8 (6), 3167-3181, 2019 | 227 | 2019 |
| Emerging epidemic of inflammatory bowel disease in a middle income country: a nation-wide study from Iran MM Malekzadeh, H Vahedi, K Gohari, P Mehdipour, SG Sepanlou, ... Archives of Iranian medicine 19 (1), 0-0, 2016 | 99 | 2016 |
| Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: Back to the future A Asadi, M Abdi, E Kouhsari, P Panahi, M Sholeh, N Sadeghifard, ... Journal of global antimicrobial resistance 22, 161-174, 2020 | 52 | 2020 |
| Endoscopic screening for esophageal squamous cell carcinoma G Roshandel, A Nouroozy, A Pourshams, S Semnani, S Merat, ... Archives of Iranian medicine 16 (6), 0-0, 2013 | 51 | 2013 |
| Temporal and geographical variations in colorectal cancer incidence in Northern Iran 2004–2013 S Hasanpour-Heidari, A Fazel, S Semnani, SR Khandoozi, T Amiriani, ... Cancer epidemiology 59, 143-147, 2019 | 32 | 2019 |
| Relationship between p53 expression and gastric cancers in cardia and antrum R Azarhoush, AALI KESHTKAR, T AMIRIAN, V KAZEMINEZHAD ARCHIVES OF IRANIAN MEDICINE 11 (5), 502-506, 2008 | 31 | 2008 |
| Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran F Nejadi-Kelarijani, G Roshandel, S Semnani, A Ahmadi, B Faghani, ... Asian Pacific Journal of Cancer Prevention 15 (17), 7433-7436, 2014 | 30 | 2014 |
| Serum leptin levels and irritable bowel syndrome: a new hypothesis S Semnani, G Roshandel, A Keshtkar, L Najafi, T Amiriani, M Farajollahi, ... Journal of clinical gastroenterology 43 (9), 826-830, 2009 | 29 | 2009 |
| SD1000: high sustained viral response rate in 1361 patients with hepatitis C genotypes 1, 2, 3, and 4 using a low-cost, fixed-dose combination tablet of generic sofosbuvir and … S Merat Clinical infectious diseases 70 (10), 2206-2212, 2020 | 28 | 2020 |
| Effect of Lactocare® synbiotic on disease severity in ulcerative colitis: a randomized placebo-controlled double-blind clinical trial T Amiriani, N Rajabli, M Faghani, S Besharat, G Roshandel, AA Tabib, ... Middle East journal of digestive diseases 12 (1), 27, 2020 | 27 | 2020 |
| The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment H Poustchi, S Majd Jabbari, S Merat, AH Sharifi, AA Shayesteh, ... Journal of Gastroenterology and Hepatology 35 (9), 1590-1594, 2020 | 25 | 2020 |
| Recent cancer incidence trends and short-term predictions in Golestan, Iran 2004–2025 G Roshandel, J Ferlay, S Semnani, A Fazel, M Naeimi-Tabiei, M Ashaari, ... Cancer epidemiology 67, 101728, 2020 | 24 | 2020 |
| Effects of omeprazole consumption on serum levels of trace elements H Joshaghani, T Amiriani, G Vaghari, S Besharat, A Molana, M Badeleh, ... Journal of Trace Elements in Medicine and Biology 26 (4), 234-237, 2012 | 21 | 2012 |
| Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis E Kouhsari, N Sadeghifard, A Khadiv, H Sayadi, T Amiriani, S Ghafourian, ... Annals of Clinical Microbiology and Antimicrobials 21 (1), 19, 2022 | 20 | 2022 |
| Increased expression of MiR-27a and MiR-24-2 in esophageal squamous cell carcinoma M Maghsudlu, E Farashahi Yazd, T Amiriani Journal of gastrointestinal cancer 51, 227-233, 2020 | 19 | 2020 |
| Novel targets in rectal cancer by considering lncRNA–miRNA–mRNA network in response to Lactobacillus acidophilus consumption: a randomized clinical trial Z Khodaii, M Mehrabani Natanzi, S Khalighfard, M Ghandian Zanjan, ... Scientific Reports 12 (1), 9168, 2022 | 18 | 2022 |
| Association between Helicobacter pylori colonization and inflammatory bowel disease: a systematic review and meta-analysis H Shirzad-Aski, S Besharat, S Kienesberger, A Sohrabi, G Roshandel, ... Journal of Clinical Gastroenterology 55 (5), 380-392, 2021 | 17 | 2021 |
| Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy? M Tajaldini, M Saeedi, T Amiriani, AH Amiriani, S Sedighi, M Dehghan, ... European Journal of Pharmacology 928, 175087, 2022 | 15 | 2022 |
| A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low-to middle-income setting S Hariri, M Sharafkhah, M Alavi, G Roshandel, A Fazel, T Amiriani, ... Harm Reduction Journal 17, 1-9, 2020 | 14 | 2020 |
| Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy E Patrad, S Khalighfard, T Amiriani, V Khori, AM Alizadeh Cellular Oncology 45 (6), 1073-1117, 2022 | 13 | 2022 |
